Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.40    0.00 (0.00%)
Bid:
7.30
Ask:
7.50
Spread: 0.20 (2.74%)
Market Cap: £3.24m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Issue of Equity

3 Jun 2015 07:00

RNS Number : 0178P
Feedback PLC
03 June 2015
Β 

3 June 2015

Feedback plc

("Feedback" or the "Company")

Issue of Equity

Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce that it has placed 11,111,111 new ordinary shares of 0.25 pence each (the "Placing Shares") at a price of 1.8 pence per ordinary share with a number of existing and new investors raising Β£200,000 (the "Placing"). The Placing has been completed by Peterhouse Corporate Finance Limited.

The proceeds of the Placing will fund continuing development of the TexRAD software.

The Placing includes participation by two of Feedback's directors, Tom Charlton who invested Β£50,400 for 2,800,000 Placing Shares and Trevor Brown who invested Β£18,000 for 1,000,000 Placing Shares (the "Participating Directors") both at a price of 1.8 pence per ordinary share. Following the Placing, the Participating Directors will be interested in a total of 104,613,919 ordinary shares in the Company representing 51.83% of the enlarged issued share capital of the Company. The shareholdings of the Participating Directors on completion of the Placing will be as follows:

Director

No. of Shares

%

Trevor Brown

55,089,111

27.29

Tom Charlton

49,524,808

24.53

The Placing Shares will rank pari passu with the existing Ordinary Shares and application will be made for the Placing Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings in the Placing Shares will commence by 8.00 a.m. on 8 June 2015.

Following Admission of the Placing Shares, the Company's enlarged issued share capital will consist of 201,857,857 ordinary shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Related Party Transaction:

Due to the fact that Trevor Brown and Tom Charlton are directors of the Company and the size of their respective shareholdings, their participation in the Placing constitutes a related party transaction as defined in the AIM Rules. Simon Barrell, Non-Executive Chairman, has not participated in the Placing and is therefore deemed to be independent under the AIM Rules for the purposes of considering the related party transaction (the "Independent Director"). The Independent Director, having consulted with Sanlam Securities UK Limited, the Company's nominated adviser, considers that the terms of the participation in the Placing by the Participating Directors are fair and reasonable insofar as the Company's shareholders are concerned.

For further information please contact:

Feedback plc

Tel: 01954 718072

Simon Barrell / Trevor Brown / Tom Charlton

Β 

Sanlam Securities UK (Nominated Adviser and Joint Broker)

Tel: 020 7628 2200

Simon Clements / Virginia Bull/ Andrew Wagstaff

Β 

Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Lucy Williams / Duncan Vasey

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEMMGGVGZFGKZZ
Date   Source Headline
22nd Apr 20262:10 pmRNSGrant of Options and PDMR dealing
20th Apr 20267:00 amRNSNHS Progress and Business Update
17th Feb 202610:43 amRNSCorrection: Half-year Report
17th Feb 20267:00 amRNSHalf-year Report
2nd Feb 20267:00 amRNSNotice of Results & Retail Investor Presentation
5th Jan 20264:13 pmRNSHolding(s) in Company
23rd Dec 20253:44 pmRNSHolding(s) in Company
23rd Dec 20253:44 pmRNSHolding(s) in Company
23rd Dec 20253:33 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:33 pmRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSTrading Update
20th Oct 20257:00 amRNSDirectorate Change
13th Oct 20254:04 pmRNSResult of AGM
18th Sep 20251:07 pmRNSNotice of AGM
17th Sep 20257:00 amRNSFinal Results
8th Sep 20257:00 amRNSNotice of Results & Retail Investor Presentation
10th Jul 20257:00 amRNSGrant of Options and PDMR dealing
12th Jun 20257:00 amRNS-RNeighbourhood Health Service Simulation
7th May 202510:44 amRNSHolding(s) in Company
6th May 20251:01 pmRNSHolding(s) in Company
28th Apr 20257:00 amRNSTrading Update
25th Feb 20257:00 amRNSHalf-year Report
11th Feb 20257:00 amRNSNotice of Results & Investor Presentation
14th Jan 20257:00 amRNSSurrender and grant of options and PDMR dealings
18th Dec 20243:07 pmRNSHolding(s) in Company
18th Dec 20247:00 amRNSHalf Year Trading Update
9th Dec 202410:56 amRNSHolding(s) in Company
9th Dec 202410:48 amRNSHolding(s) in Company
4th Dec 20247:00 amRNSHolding(s) in Company
3rd Dec 202412:33 pmRNSHolding(s) in Company
3rd Dec 202412:18 pmRNSHolding(s) in Company
2nd Dec 202411:53 amRNSHolding(s) in Company
2nd Dec 202411:46 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20243:36 pmRNSHolding(s) in Company
29th Nov 20243:33 pmRNSHolding(s) in Company
28th Nov 20242:35 pmRNSResult of AGM & Commercial Update
6th Nov 20247:00 amRNSResult of WRAP Retail Offer
4th Nov 20243:46 pmRNSSuccessful Fundraising upscaled to c. £5.57m
4th Nov 20247:02 amRNSWRAP Retail Offer for up to £1 million
4th Nov 20247:01 amRNSProposed Fundraise & Share Capital Reorganisation
4th Nov 20247:00 amRNSFinal Results
16th Oct 20247:00 amRNSElective Recovery Fund funding mechanism
19th Sep 20247:00 amRNSCollaboration Agreement
2nd Sep 20247:00 amRNSFurther funding to extend NHS Trust pathways
10th Jul 20247:00 amRNSVertex In Healthcare Collaboration
1st Jul 20247:00 amRNSCDC Contract Awarded by Queen Victoria Hospital
28th Jun 20247:00 amRNSChange of Name of Nominated Adviser and Broker
22nd May 20247:00 amRNSTrading Update
25th Mar 20247:00 amRNSNew tuberculosis partnership in India

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.